Incyte | INCY - Créanciers Commerciaux

Prix De L'Action
91.22
Variation Quotidienne
-1.73 -1.86%
Mensuellement
-9.54%
Annuel
47.32%
Q1 Prévisions
89.75




Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agenus USD 82.99M 2.3M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Gilead Sciences USD 808M 226M 2025-09
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
MacroGenics USD 4.79M 1.15M 2025-12
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12